Education
About Us
Working with TipRanks
Follow Us
BioLife Solutions (BLFS)
NASDAQ:BLFS
BLFS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$14.84 - $29.55
Previous CloseN/A
Volume44.73K
Average Volume (3M)287.62K
Market Cap
$1.17B
Enterprise Value$1.16B
Total Cash (Recent Filing)$29.73M
Total Debt (Recent Filing)$40.96M
Price to Earnings (P/E)―
Beta2.41
Next Earnings
May 08, 2025EPS Estimate
-0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.26
Shares Outstanding47,000,000
10 Day Avg. Volume374,618
30 Day Avg. Volume287,618
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)9.46
Price to Cash Flow (P/CF)60.80
P/FCF Ratio60.80
Enterprise Value/Market Cap0.99
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit20.11
Enterprise Value/Ebitda-53.60
Forecast
1Y Price Target
$31.33Price Target Upside19.35% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
---
BioLife Solutions News
PremiumCompany Announcements
BioLife Solutions Reports Strong 2024 Financial Growth
PremiumCompany Announcements
BioLife Solutions Inc. Projects Strong 2025 Growth---
Bulls Say, Bears Say
Bulls Say
Revenue GrowthCell processing revenue showed significant growth, up 43% YoY, marking the fourth consecutive quarter of growth.
Strategic RealignmentBiolife has taken several steps to re-align its focus with its higher-margin, 'sticky', cell processing platform, concluding with the divestiture of its freezer business.
Bears Say
Revenue GuidanceBioLife lowered revenue guidance to $98M-$100M, from $99M-$101M, to factor in the reduction of the SciSafe divestiture.
---
Ownership Overview
21.99% Insiders
24.39% Mutual Funds
0.51% Other Institutional Investors
35.50% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BLFS FAQ
What was BioLife Solutions’s price range in the past 12 months?
BioLife Solutions lowest stock price was $14.84 and its highest was $29.55 in the past 12 months.
What is BioLife Solutions’s market cap?
BioLife Solutions’s market cap is $1.17B.
When is BioLife Solutions’s upcoming earnings report date?
BioLife Solutions’s upcoming earnings report date is May 08, 2025 which is in 63 days.
How were BioLife Solutions’s earnings last quarter?
BioLife Solutions released its earnings results on Mar 03, 2025. The company reported -$0.04 earnings per share for the quarter, beating the consensus estimate of -$0.06 by $0.02.
Is BioLife Solutions overvalued?
According to Wall Street analysts BioLife Solutions’s price is currently Undervalued.
Does BioLife Solutions pay dividends?
BioLife Solutions does not currently pay dividends.
What is BioLife Solutions’s EPS estimate?
BioLife Solutions’s EPS estimate is -0.05.
How many shares outstanding does BioLife Solutions have?
BioLife Solutions has 47,000,000 shares outstanding.
What happened to BioLife Solutions’s price movement after its last earnings report?
BioLife Solutions reported an EPS of -$0.04 in its last earnings report, beating expectations of -$0.06. Following the earnings report the stock price went up 2.125%.
Which hedge fund is a major shareholder of BioLife Solutions?
Currently, no hedge funds are holding shares in BLFS
---
BioLife Solutions Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$31.33 (19.35% Upside)
$31.33 (19.35% Upside)
Blogger Sentiment
Bullish
BLFS Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 24.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.6%
Last 30 Days ▲ 2.0%
Last 30 Days ▲ 2.0%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
54.23%
12-Months-Change
Fundamentals
Return on Equity
-6.14%
Trailing 12-Months
Asset Growth
-2.03%
Trailing 12-Months
Company Description
BioLife Solutions
BioLife Solutions, Inc. engages in the development, manufacture, and marketing of biopreservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1998 and it is headquartered in Bothell, WA.
---
BLFS Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call for BioLife Solutions reflected a positive outlook with significant achievements in strategic portfolio reshaping, improved financial metrics, and a strong cash position. Despite some declines in specific platform revenues and ongoing operating losses, the company is well-positioned for growth in 2025 with record Cell Processing revenue and a strong growth outlook.Read More>---
BLFS Revenue Breakdown
45.91% Cell processing
36.05% Freezer and thaw
18.04% Biostorage services
---
BLFS Stock 12 Month Forecast
Average Price Target
$31.33
▲(19.35% Upside)
Technical Analysis
Best Analysts Covering BLFS
1 Year
1 Year Success Rate
8/11 ratings generated profit
1 Year Average Return
+36.75%
reiterated a buy rating 3 days ago
Copying Matt Hewitt's trades and holding each position for 1 Year would result in 72.73% of your transactions generating a profit, with an average return of +36.75% per trade.
---